双叶机械瓣假体三十年应用经验
本研究评估St Jude Medical机械瓣植入后的长期结局,1979年至2014年共纳入1023例患者,其中主动脉瓣置换584例、二尖瓣置换439例。随访95%完整,结果显示30年无再手术、血栓栓塞、瓣膜血栓、出血和心内膜炎的比率在主动脉瓣置换与二尖瓣置换患者中各有报告,结论认为该机械瓣在密切随访下仍是可靠的假体。
要点
- 主动脉瓣置换患者30年生存率14%±3%,二尖瓣置换患者30年生存率14%±3%。
- 主动脉瓣置换患者30年无血栓栓塞率79%±3%,二尖瓣置换患者55%±6%。
- 出血发生率主动脉瓣置换2.5%/患者年,二尖瓣置换2.0%/患者年。
核心结论
- 经过三十年密切随访,St Jude Medical机械瓣仍被认为是可靠的假体。
研究设计与样本
- 主动脉瓣置换584例,二尖瓣置换439例,随访完整率95%。
主要发现
- 主动脉瓣置换患者手术死亡率3%(17/584),二尖瓣置换患者4%(18/439)。
- 主动脉瓣置换患者10、20、30年晚期生存率分别为62%±2%、32%±2%、14%±3%。
- 二尖瓣置换患者10、20、30年晚期生存率分别为64%±3%、28%±3%、14%±3%。
- 主动脉瓣置换患者30年无再手术、血栓栓塞、瓣膜血栓、出血、心内膜炎率分别为92%±2%、79%±3%、96%±1%、56%±5%、92%±2%。
- 二尖瓣置换患者30年无再手术、血栓栓塞、瓣膜血栓、出血、心内膜炎率分别为85%±5%、55%±6%、99%±1%、57%±6%、95%±2%。
关键数值与推荐
- 主动脉瓣置换患者出血发生率2.5%/患者年,血栓栓塞发生率1.6%/患者年。
- 二尖瓣置换患者出血发生率2.0%/患者年,血栓栓塞发生率2.9%/患者年。
临床怎么用
- 对于植入St Jude Medical机械瓣的患者,应坚持年度随访以识别瓣膜相关事件。
- 主动脉瓣置换与二尖瓣置换患者长期抗凝相关出血和血栓栓塞风险存在差异,需个体化评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective was to evaluate the long-term outcomes of the St Jude Medical (Saint Paul, Minn) mechanical valve prosthesis implantation. METHODS: Since 1979, every patient receiving this prosthesis has been followed annually. RESULTS: From January 1979 to December 2014, 1023 patients were accrued. Patients' ages ranged from 18 to 85 years. Aortic valve replacement was performed in 584 patients, and mitral valve replacement was performed in 439 patients. Follow-up was 95% complete. Operative mortality was 3% (17/584, aortic valve replacement) and 4% (18/439, mitral valve replacement). In patients undergoing aortic valve replacement, late actuarial survival was 62% ± 2%, 32% ± 2%, and 14% ± 3% at 10, 20, and 30 years, respectively. Thirty-year freedom from reoperation, thromboembolism, valve thrombosis, bleeding, and endocarditis was 92% ± 2%, 79% ± 3%, 96% ± 1%, 56% ± 5%, and 92% ± 2%, respectively. In patients undergoing mitral valve replacement, late actuarial survival was 64% ± 3%, 28% ± 3%, and 14% ± 3% at 10, 20, and 30 years, respectively. Thirty-year freedom from reoperation, thromboembolism, valve thrombosis, bleeding, and endocarditis was 85% ± 5%, 55% ± 6%, 99% ± 1%, 57% ± 6%, and 95% ± 2%, respectively. The incidence of bleeding was 2.5% and 2.0% per patient-year for aortic valve replacement and mitral valve replacement, respectively. The incidence of thromboembolism was 1.6% and 2.9% per patient-year for aortic valve replacement and mitral valve replacement, respectively. CONCLUSIONS: Annual follow-up of all of our patients receiving a St Jude Medical mechanical valves prosthesis has allowed better identification valve-related issues and events. After 3 decades of observation with close follow-up, the St Jude Medical mechanical valve continues to be a reliable prosthesis.
引用
- Johnson S, Stroud MR, Kratz JM, et al. Thirty-year experience with a bileaflet mechanical valve prosthesis. J Thorac Cardiovasc Surg. 2018. PMID: 30342758. doi:10.1016/j.jtcvs.2018.09.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。